Skip to main content
. 2016 Jun 9;82(3):849–857. doi: 10.1111/bcp.12995

Table 1.

Descriptive statistics for participants at baseline (wave 1) and follow‐up (wave 2)

Baseline (Wave 1) (n = 2051) Follow‐up (Wave 2) (n = 1753)
Age (years, mean (SD)) 74.8 (6.17) 76.5 (6.04)
Age group (years, n (%))
65–74 1087 (53.0) 754 (43.0)
≥75 964 (47.0) 999 (57.0)
Gender (Female, n (%)) 1107 (54.0) 953 (54.4)
Number of repeat drug classes (median (IQR)) 5 (3‐8) 6 (3‐9)
Number of reported conditions (n (%))
0 214 (10.4) 88 (5.0)
1 423 (20.6) 268 (15.3)
2 498 (24.3) 370 (21.1)
3 or more 916 (44.7) 1027 (58.6)
Level of education attainment (n (%))
None/primary 1056 (51.5) 879 (50.2)
Secondary 642 (31.3) 565 (32.3)
Third/higher 351 (17.1) 308 (17.6)
Living arrangements (n (%))
Living alone 718 (35.0) 626 (30.5)
Living with spouse 965 (47.1) 793 (38.7)
Living with others 368 (17.9) 632 (30.8)
Private health insurance (n (%)) 891 (43.4) 760 (43.4)
Diagnosed mental health condition (n (%)) 129 (6.3) 157 (9.0)
Any hospital admission (n (%)) 354 (17.3) 366 (20.9)
Moderate activity (n (%)) 799 (39.0) 751 (42.8)
Depressive symptoms (n (%)) *
None 1172 (58.2) 1248 (74.9)
Sub‐clinical 613 (30.4) 277 (16.6)
Clinical 230 (11.4) 141 (8.5)
Social participation (n (%)) 943 (46.0) 826 (47.1)
*

Depressive symptoms measured by Centre for Epidemiological Studies Depression scale missing for 36 participants at baseline and 87 participants at follow‐up.